Zydus Pharmaceuticals Recalls Entecavir Tablets Over Impurity Issues
Zydus Pharmaceuticals recalled 600 bottles of Entecavir Tablets on September 24, 2025. The recall follows a failed impurity specification that poses health risks. Consumers should stop using the product immediately and contact healthcare providers for guidance.
Product Details
The recalled product is Entecavir Tablets, USP, 1 mg, in 30-count bottles. It was manufactured by Zydus Lifesciences Ltd. and distributed by Zydus Pharmaceuticals (USA) Inc. Lot number is E409309 with an expiration date of December 31, 2026.
The Hazard
The recall involves tablets that failed to meet impurity and degradation specifications. The affected tablets may contain an unapproved organic impurity.
Reported Incidents
No specific injuries or adverse events have been reported related to this recall. The FDA classified this recall as Class II, indicating a potential risk of serious health consequences.
What to Do
Stop using the Entecavir Tablets immediately. Contact Zydus Pharmaceuticals (USA) Inc. or your healthcare provider for further instructions and guidance.
Contact Information
Consumers can reach Zydus Pharmaceuticals at 1-800-XYZ-XXXX. For more information, visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0002-2026.